Cardiff Oncology
CRDF
21 hedge funds and large institutions have $12.3M invested in Cardiff Oncology in 2014 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 7 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
5% less funds holding
Funds holding: 22 → 21 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
40% less capital invested
Capital invested by funds: $20.6M → $12.3M (-$8.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$385K |
| 2 |
DIA
Denver Investment Advisors
Denver,
Colorado
|
+$108K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$90.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$86.8K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$80.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$1.13M |
| 2 |
AGM
Alpine Global Management
New York
|
-$143K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$72K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$56.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$30K |
CRDF Hedge Fund Activity: Q2 2014 in Review
21 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q2 2014, worth a combined $12.3M — down 40% from $20.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CRDF and 6 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 6 added.
The largest buyer was Morgan Stanley, adding an estimated $385K. The largest seller was Rhenman & Partners Asset Management, exiting entirely with an estimated $1.13M sold.
- 21 institutional investors held Cardiff Oncology (CRDF) as of Q2 2014, down from 22 in Q1 2014.
- Funds reported $12.3M of Cardiff Oncology stock for Q2 2014, down 40% quarter-over-quarter.
- 6 funds opened new Cardiff Oncology positions in Q2 2014 and 7 closed out, a net change of -1 holder.
- The largest Cardiff Oncology buyer in Q2 2014 was Morgan Stanley, an estimated $385K added.
- The largest Cardiff Oncology seller in Q2 2014 was Rhenman & Partners Asset Management, an estimated $1.13M sold.
Based on aggregated 13F filings for Q2 2014.